Pfizer’s COVID-19 vaccine has now been shipped off all over the United States but because of the rushed results, there are still some kinks to iron out in the formula.
After nearly a year of lockdowns and restrictions that the economic impact that came with it, the entire country is getting impatient waiting for it to be over.
One big problem is that many Americans still aren’t sure about getting a vaccination that was pushed out to the public so quickly. And don’t even get me started on anti-vaxxers.
Polls show that around 60% of the nation’s citizens are still uncomfortable with the idea.
And while many people have already gotten the vaccine with no problem, there was one case of an adverse reaction in Alaska that has raised some concerns.
An Alaska healthcare worker who suffered an allergic reaction to Pfizer’s Covid-19 vaccine on Tuesday felt flushed within the first 10 minutes of receiving the vaccine, and later reported symptoms including shortness of breath and elevated heart rate, doctors said Wednesday.
The case is the first allergic reaction to the vaccine to be reported in the US, although health officials said they are expecting the occasional allergic reaction — and are prepared to treat anyone suffering from one.
Officials were prepared for this, however.
“We expected that a side effect like this could occur after reports of anaphylaxis were made in England after people there received the Pfizer-BioNTech Covid-19 vaccine,” said Alaska’s Chief Medical Officer Dr. Anne Zink. “All sites that are approved to provide vaccinations in Alaska must have medications on hand to deal with an allergic reaction and that was the case in Juneau.”
The Pfizer vaccine has been sent to all fifty states and thousands of people have received the two-part shot. This is the first case of an allergic reaction in the United States.